With many GLP-1 agonists available, patients and their HCPs will need to decide which of these will serve them best
Researchers investigate PT-141 for understanding melanocortin receptor biology and physiological responses.nnPT-141 Research FocusnnPreclinical studies examine PT-141 for:n- Melanocortin receptor activation and signalingn- Neural pathway modulation in arousal circuitsn- Motivation and reward system researchn- Mood and stress response effectsn- Skin pigmentation pathways (secondary to primary mechanism)n- Appetite and energy regulation explorationn- Cardiovascular and metabolic MC4R effectsnnProduct Specificationsn| Compound | PT-141 (Bremelanotide) melanocortin agonist |n| Quantity | 10mg per vial |n| Form | Lyophilized powder |n| Purity | 99% HPLC verified |n| Storage | -20C lyophilized
Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes mellitus treated with metformin: EXENDA, a 24week, prospective, randomized, placebocontrolled pilot trial
Lipo-C peptide is intended strictly for research and laboratory use only
Selank: Also associated with Russian research, commonly discussed for calm focus, stress response, mood balance, and anxiety-like symptoms